Sun Pharma share price falls 3% after US FDA conducts inspection in Baska facility. Should you buy, sell or hold?

According to an exchange filing, the pharma major said the inspection took place between September 8 and September 19, 2025, following which the US FDA classified the facility under Official Action Indicated (OAI) status.